Low Leukocyte MGMT Accompanies Temozolomide-Induced Myelotoxicity in Brain Tumor Patients . Journal of Cancer Research Updates, [S. l.], v. 1, n. 1, p.  44–48, 2012. DOI: 10.6000/1929-2279.2012.01.01.08. Disponível em: https://www.neoplasiaresearch.com/index.php/jcru/article/view/372. Acesso em: 2 may. 2026.